Product Details

Teva-Irbesartan HCTZ

Irbesartan + Hydrochlorothiazide
150 mg + 12.5 mg
Tablet


DIN/PIN/NPN

02330512

Manufacturer

Teva Canada Limited

Formulary Listing Date

2011-08-04  

Unit Price

0.2281

Amount MOH Pays

0.2281

Coverage Status

General Benefit Chronic-Use Medication

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

C09DA04

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02330512 Teva-Irbesartan HCTZ 0.2281 0.2281
02337428 Sandoz Irbesartan HCT 0.2281 0.2281
02363208 Ran-Irbesartan HCTZ 0.2281 0.2281
02328518 PMS-Irbesartan-HCTZ 0.2281 0.2281
02392992 Mint Irbesartan/HCTZ 0.2281 0.2281
02418223 Jamp-Irbesartan and Hydrochlorothiazide 0.2281 0.2281
02372886 Irbesartan/HCTZ 0.2281 0.2281
02385317 Irbesartan HCT 0.2281 0.2281
02357399 Co Irbesartan/HCT 0.2281 0.2281
02241818 Avalide 1.3166 0.2281
02447878 Auro-Irbesartan HCT 0.2281 0.2281
02387646 Apo-Irbesartan/HCTZ 0.2281 0.2281
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph